Benzinga | Oct 28, 2021 04:05PM EDT

Seattle Genetics Q3 EPS $(1.61) May Not Compare To $(0.57) Estimate, Sales $424.06M Beat $384.65M Estimate

Seattle Genetics (NASDAQ:SGEN) reported quarterly losses of $(1.61) per share which missed the analyst consensus estimate of $(0.57) by 182.46 percent. This is a 146 percent decrease over earnings of $3.50 per share from the same period last year. The company reported quarterly sales of $424.06 million which beat the analyst consensus estimate of $384.65 million by 10.25 percent. This is a 60.07 percent decrease over sales of $1.06 billion the same period last year.